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Introduction
Enhanced expression of the c-myc oncogene is a hallmark of 
multiple human tumors, and many experiments using transgenic 
animals document the oncogenic potential of deregulated c-myc 
expression (Oster et al., 2002). c-myc encodes a nuclear protein 
(Myc) that forms several distinct chromatin-bound complexes 
(Eilers and Eisenman, 2008). As part of a binary complex with 
a partner protein, Max, Myc binds to specific DNA sequences 
termed E-boxes and activates transcription of RNA polymerase 
II–dependent genes. Myc represses transcription when the   
Myc/Max heterodimer is recruited to core promoter sequences   
by the zinc finger transcription factor Miz1.
Several genome-wide expression and DNA-binding stud-
ies show that Myc has an extraordinary large number of binding 
sites and target genes and can enhance the expression of large 
groups of genes. In contrast, the spectrum of target genes of the 
Myc–Miz1 complex is more limited; among its best character-
ized targets are those encoding the cyclin-dependent kinase in-
hibitors p15Ink4b, p21Cip1, and p57Kip2 and a group of genes 
encoding proteins involved in cell–cell and cell–matrix adhesion 
(Staller et al., 2001; Seoane et al., 2002; Gebhardt et al., 2006). 
In the absence of Myc, Miz1 binds to the core promoter of 
these genes and activates their expression in response to anti-
mitogenic signals; for example, addition of TGF- (Seoane   
et al., 2001, 2002; Staller et al., 2001), exposure to DNA dam-
age (Seoane et al., 2002), and disturbance of protein translation 
(Wanzel et al., 2008) can all activate Miz1 function. To activate 
its target genes, Miz1 needs to bind to nucleophosmin (NPM; 
Wanzel et al., 2008). In unstressed cells, NPM shuttles between 
cytosol and nucleolus and acts as a chaperone for the nuclear 
export of ribosomal subunits; at steady state, the majority of 
NPM resides in the nucleolus (Maggi et al., 2008). Exposure 
of cells to stress such as DNA damage leads to accumulation of 
a fraction of NPM in the nucleus, where it interacts with Miz1 
to activate its target genes.
Both NPM and Myc also interact with the alternate read-
ing frame (Arf) tumor suppressor protein (Bertwistle et al., 2004; 
Qi et al., 2004; Korgaonkar et al., 2005). Arf is not expressed 
under physiological conditions, but its expression is induced   
in response to oncogenic stress signals (Zindy et al., 2003). 
O
ncogenic stress induces expression of the alter-
nate  reading  frame  (Arf)  tumor  suppressor 
protein. Arf then stabilizes p53, which leads to 
cell cycle arrest or apoptosis. The mechanisms that distin-
guish both outcomes are incompletely understood. In this 
study, we show that Arf interacts with the Myc-associated 
zinc finger protein Miz1. Binding of Arf disrupts the inter-
action of Miz1 with its coactivator, nucleophosmin, induces 
the sumoylation of Miz1, and facilitates the assembly of 
a heterochromatic complex that contains Myc and trimeth-
ylated H3K9 in addition to Miz1. Arf-dependent assem-
bly of this complex leads to the repression of multiple genes 
involved in cell adhesion and signal transduction and in-
duces apoptosis. Our data point to a tumor-suppressive 
pathway that weakens cell–cell and cell–matrix interac-
tions  in  response  to  expression  of  Arf  and  that may 
thereby facilitate the elimination of cells harboring an   
oncogenic mutation.
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Figure 1.  In vivo interaction of Arf with Miz1. (a) p14Arf and Miz1 form a complex after ectopic expression in HeLa cells. Where indicated (+), cells were 
transfected with CMV-driven expression plasmids encoding Miz1 or p14Arf. 48 h later, lysates were immunoprecipitated with the indicated antibodies. 
(left) Input blots are shown. (right) The results of the coimmunoprecipitation experiments are shown. IP, immunoprecipitate. (b) Interaction of endogenous 
Miz1 and p14Arf. (left) HeLa cells were lysed, and lysates were immunoprecipitated with control (ctr), -p14Arf, or -Miz1 antibodies; immunoblots of the 
precipitates were probed with the indicated antibodies. (right) To confirm that coprecipitation of p14Arf with -Miz1 antibodies is not caused by antibody 
cross reactivity, cells were transfected with siRNA targeting Miz1 72 h before harvesting. Immunoprecipitation was performed as described in a. The 
arrowhead points to Miz1, and the asterisk denotes a nonspecific band. (c) Miz1 recruits p14Arf from the nucleolus to the nucleoplasm. HeLa cells were 
transfected with the indicated expression plasmids and fixed 48 h later. Indirect immunofluorescence was performed using the indicated antibodies. The 
localization of ectopically expressed p14Arf (top) and the localization of endogenous p14Arf (bottom) are shown. Note that Miz1 does not affect total 
levels of either ectopically expressed or endogenous Arf proteins. (d) Murine p19Arf interacts with Miz1. NPM
//p53
/ MEFs were transfected with 907 Arf inhibits Miz1 • Herkert et al.
the nucleolus, whereas Miz1 is localized in the nucleoplasm, 
raising the question of where the Miz1–Arf complex might   
reside. Ectopic expression of Miz1 did not affect levels of Arf 
protein but recruited both ectopically expressed and endogenous 
p14Arf protein from the nucleolus to the nucleoplasm (Fig. 1 c). 
Similar  to  human  p14Arf,  murine  p19Arf  associated  with   
Miz1 when both proteins were ectopically expressed (Fig. 1 d). 
Furthermore,  immunoprecipitations  from  mouse  embryonic 
fibroblasts (MEFs) that lack p53 and NPM and express elevated 
levels of endogenous p19Arf showed that a significant fraction 
of endogenous Miz1 and a smaller fraction of endogenous Arf 
were associated with each other in these cells (Fig. 1 e). Collec-
tively, the data show that Miz1 and Arf are associated with each 
other in human and mouse cells.
Miz1 requires binding to NPM for transcriptional activa-
tion of its target genes (Wanzel et al., 2008). Because NPM 
forms a stoichiometric complex with p14Arf, this raises the 
possibility that binding of Arf to Miz1 occurs indirectly via 
NPM (Itahana et al., 2003; Bertwistle et al., 2004; Korgaonkar 
et al., 2005). To determine whether this is the case, we expressed 
Miz1 and p14Arf in MEFs lacking both NPM and p53 (Fig. 1 f; 
Colombo et al., 2005). Miz1 and p14Arf efficiently bound to 
each other in such cells, and restoration of NPM reduced rather 
than enhanced the amount of Arf that was bound to Miz1.   
Furthermore, interaction of Miz1 with Arf did not require the 
amino-terminal POZ domain of Miz1, which is required for 
transcriptional activation and interaction with NPM (Fig. S1 a). 
Similarly, both Miz1 and Myc interact with p14Arf, suggesting 
that Myc might be required for Arf to interact with Miz1 (Qi   
et  al.,  2004);  however,  Myc  and  Miz1  bound  to  different   
domains of Arf (see Fig. 3 a). We concluded that Miz1 binds to 
p14Arf independently of its interactions with Myc and NPM.
To determine the functional consequences of the inter-
action of p14Arf with Miz1, we performed reporter assays using   
a P15INK4B promoter plasmid (Fig. 2 a). Consistent with pre-
vious results, Miz1 enhanced P15INK4B promoter activity   
(Wanzel et al., 2008). Expression of p14Arf had no effect on the 
basal activity of the promoter but abrogated Miz1-dependent 
transactivation. Identical results were obtained using a P21CIP1 
reporter plasmid (unpublished data).
Ectopic expression of Miz1 inhibits cell proliferation in a 
p21-dependent manner in the G1 phase of the cell cycle and in 
a p21-independent manner in the S and G2 phases of the cell 
cycle (Herold et al., 2008). To ascertain whether Arf affects 
Miz1-dependent cell cycle arrest, we expressed Miz1 alone or 
together with (murine) p19Arf by retroviral infection in triple-
knockout MEFs that lack p53, mdm2, and arf (Weber et al., 
2000). Expression of Miz1 by itself induced an accumulation of 
cells in the G1 phase of the cell cycle (Fig. 2 b). Coexpression 
of p19Arf abrogated the Miz1-induced G1 arrest and shifted the 
Arf stabilizes p53 because it inhibits the Mdm2 and HectH9   
(Arf-Bp1) ubiquitin ligases that degrade p53 in unstressed cells 
(Stott et al., 1998; Zhang et al., 1998; Chen et al., 2005). Arf 
also contributes to the cellular stress response by inhibiting the 
functions of NPM in ribosome assembly (Itahana et al., 2003; 
Bertwistle et al., 2004). Finally, Arf induces the sumoylation of 
proteins to which it binds, including NPM; this may be medi-
ated by its ability to inhibit the Sumo protease Senp3 and trigger 
its degradation via the proteasome (Tago et al., 2005; Haindl   
et al., 2008; Kuo et al., 2008).
Ectopic expression of Arf induces G1 arrest, but it is also 
required for oncogene-induced senescence and apoptosis, argu-
ing that mechanisms must exist that regulate these cellular   
responses to induction of Arf (Kamijo et al., 1997; Zindy et al., 
1998). How a cell chooses between G1 arrest and apoptosis in 
response to expression of Arf is unclear. One factor that favors 
apoptosis is enhanced expression of Myc, and Arf-dependent 
apoptosis limits the oncogenic potential of Myc (Zindy et al., 
1998). In this study, we show that Arf facilitates the assembly   
of a heterochromatic Myc–Miz1 complex and that this event 
provides a critical switch from G1 arrest to apoptosis in response   
to Arf expression.
Results
To test whether human p14Arf associates with Miz1, HeLa cells 
were transfected with cytomegalovirus (CMV)-driven expres-
sion vectors encoding both proteins; lysates were prepared and 
immunoprecipitated with antibodies directed against either pro-
tein. Immunoblots revealed the presence of p14Arf in -Miz1 
immunoprecipitates; conversely, Miz1 was present in -p14Arf 
precipitates (Fig. 1 a). Neither protein was present in control 
immunoprecipitates, suggesting that both proteins associate   
in vivo. To determine whether the endogenous Miz1 and p14Arf 
proteins form a complex, HeLa cell lysates were immunopre-
cipitated using specific antibodies. Immunoblotting showed that 
Miz1 was present in -p14Arf immunoprecipitates and p14Arf 
in -Miz1 immunoprecipitates; neither protein was present in 
control immunoprecipitates (Fig. 1 b). Furthermore, Myc was 
associated with both endogenous p14Arf and Miz1, confirming 
previous results (Staller et al., 2001; Qi et al., 2004). To rule out 
the idea that the reciprocal coimmunoprecipitation of p14Arf 
and Miz1 was caused by a cross reactivity of the Miz1 antibody, 
we used siRNA to deplete Miz1. Depletion of Miz1 strongly   
reduced the amount of Miz1, Myc, and p14Arf present in   
-Miz1 immunoprecipitates. Depletion of Miz1 also eliminated 
the Miz1 signal present in p14Arf immunoprecipitates but had 
no effect on the amount of p14Arf and Myc present in -p14Arf 
immunoprecipitates. We concluded that endogenous Miz1 and 
human p14Arf associate with each other. p14Arf is localized in 
expression plasmids encoding p19Arf and Miz1. Cell lysates were prepared 48 h after transfection, immunoprecipitated, and immunoblots were probed 
with p19Arf and Miz1 antibodies. (e) Endogenous p19Arf and Miz1 form a complex in NPM
//p53
/ MEFs. Cell lysates were immunoprecipitated with 
control, p19Arf, or Miz1 antibodies; immunoblots of the precipitates and input material (2%) were probed with the indicated antibodies. (f) Miz1 interacts 
with p14Arf independently of NPM. NPM
//p53
/ MEFs were transfected with expression plasmids encoding p14Arf, NPM, and Miz1 as indicated. 
Cell lysates were prepared 48 h after transfection, immunoprecipitated with the indicated antibodies, and immunoblots were probed as described in a.
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Figure 2.  p14Arf inhibits Miz1-dependent transactivation and G1 arrest. (a) p14Arf inhibits transactivation of the P15INK4B promoter by Miz1. The result 
of reporter assays using a luciferase reporter plasmid that contains the transcription start site of the P15INK4B promoter is shown. HeLa cells were transfected 
with the indicated expression plasmids, and the specific luciferase activity was determined 48 h after transfection. (b) p19Arf inhibits the Miz1-induced arrest 
in the G1 phase of the cell cycle. MEFs that are deficient for p53, Mdm2, and p19Arf were infected with retroviruses encoding Miz1, p19Arf, or both, and 
resistant cells were selected. FACS analysis was performed immediately after selection. (a and b) Error bars show the standard deviation obtained from three 
independent samples per experimental condition. (c) p14Arf does not interfere with DNA binding of Miz1. HeLa cells were transfected with expression vectors 
encoding Miz1, p14Arf, or both. Results of chromatin immunoprecipitation assays documenting the percentage of Miz1 bound to the P15INK4B promoter 
and a control (ctr) region 10 kb upstream under these conditions are shown. (d) Expression of p14Arf renders Miz1 insoluble. HeLa cells were transfected 
with expression plasmids encoding Miz1 and p14Arf as shown; in these experiments, the relative amount of CMV-p14Arf expression plasmid was higher 
than used before. Lysates were prepared using the indicated buffer conditions, cleared by centrifugation, and immunoblots of soluble extracts were probed 
with the indicated antibodies. (e) Expression of p14Arf induces relocalization of Miz1 within the nucleus. Confocal microscopy images of individual HeLa 
cell nuclei transfected with the indicated expression plasmids are shown. Rr indicates the Pearson’s coefficient for the correlation of the localization of both 
proteins. (f) Arf induces formation of heterochromatin around Miz1-binding sites. A summary of the results of chromatin immunoprecipitation (ChIP) assays   
using antibodies directed against Miz1 and trimethylated H3K9 is shown. The y axis shows the amount of chromatin recovered in -Miz1 and in -trimethylated 
H3K9 immunoprecipitates plotted as a percentage of input chromatin. For each region of the P15INK4B gene, the data are shown for cells transfected with 
expression vectors encoding Miz1 or Miz1 together with Arf (c and f). Errors bars show the standard deviation of triplicate PCR reactions.909 Arf inhibits Miz1 • Herkert et al.
with such a model, confocal microscopy revealed that both 
transfected and endogenous Myc colocalized with Miz1 foci   
after expression of Arf (Fig. 3 c and not depicted).
To test whether recruitment of Myc is required for Arf to 
inhibit Miz1 function, we used three previously characterized 
mutations of Miz1 that disrupt the Myc-binding domain local-
ized between the 12th and 13th zinc finger: one deletion (Miz1 
∆33) partially impairs Myc binding, whereas a larger deletion 
(Miz1 ∆75) and a quadruple point mutant (Miz1 4Pro) abro-
gate binding to Myc (Fig. 3 d; Peukert et al., 1997). Although 
all three mutant proteins interacted equally with Arf (Fig. 3 d), 
inhibition of Miz1 transactivation as well as sequestration   
(as indicated by their increased solubility when coexpressed 
with Arf) was moderately (∆33) or strongly (∆75 and 4Pro) 
impaired relative to wild-type Miz1 (Fig. 3, e and f). Confo-
cal microscopy confirmed that Miz1∆75 was not sequestered   
upon  coexpression  of  Arf  (Fig.  3  g).  We  concluded  that   
recruitment of Myc is essential for Arf to inhibit transactiva-
tion by Miz1.
Miz1 forms a soluble complex with NPM to activate   
transcription. Myc competes with NPM for binding to Miz1 and 
forms a complex that is resistant to mild extraction; therefore, 
the altered properties of Miz1 in response to expression of Arf 
might reflect an Arf-induced assembly of the Myc–Miz1 com-
plex (Peukert et al., 1997). To analyze how expression of Arf   
affects complex formation of Miz1 with NPM, we performed 
immunoprecipitation assays and found that expression of Arf 
led to a dissociation of Miz1 from NPM (Fig. 4 a). Strikingly, 
the converse was also true: elevated expression of NPM pre-
vented the Arf-induced decrease in solubility and the change in 
subnuclear localization of Miz1 (Fig. 1 f; and Fig. 4, b and c). 
Collectively, the data strongly suggest a model in which Arf and 
NPM antagonize each other’s function in the assembly of the 
Myc–Miz1 complex (see Fig. 8).
Expression of Arf induces sumoylation of several of its 
substrate proteins (Tago et al., 2005). Consistent with these   
observations, Miz1 colocalized with Flag-tagged Sumo2 upon 
expression of Arf but not in its absence (Fig. 4 d); this was not 
observed for Sumo1, suggesting that it is specific for Sumo2 
(not depicted). siRNA-mediated depletion showed that Ubc9, 
the E2 enzyme responsible for conjugation of Sumo moieties, 
was not required for Arf-induced sequestration of Miz1 and   
focus formation but was strictly required for recruitment of 
Sumo2 to these foci (Fig. 4 e and not depicted). In vitro su-
moylation assays revealed that Miz1 is sumoylated in vitro 
(unpublished data). Transient transfection assays showed that 
expression of Arf strongly stimulated sumoylation of Miz1   
in vivo (Fig. 4 f). In contrast, we did not detect sumoylation of 
Myc  (unpublished  data).  Depletion  of  Myc  using  specific 
siRNA reduced the Arf-dependent sumoylation of Miz1, sug-
gesting that assembly of the Myc–Miz1 complex enhances su-
moylation of Miz1; consistent with such a model, sumoylation 
of Miz1∆75 was reduced relative to wild-type Miz1 (Fig. 4 g 
and not depicted).
As shown in Fig. 2 b, Arf negates the ability of Miz1 to 
arrest proliferation of p53-deficient cells in the G1 phase of the 
cell cycle. To determine how Arf affects Miz1 function in a 
arrest to the S phase of the cell cycle, which is consistent with 
its ability to abrogate transcriptional activation by Miz1.
To understand how p14Arf inhibits transactivation by 
Miz1, we initially used chromatin immunoprecipitation assays 
to measure DNA binding of Miz1 in the absence and presence 
of p14Arf. These assays showed that expression of Arf did not 
interfere with DNA binding of Miz1 to the P15INK4B (Fig. 2 c) 
and P21CIP1 (not depicted) promoters; instead, Arf appeared to 
enhance DNA binding by Miz1 (see Fig. 6 d).
In these experiments, we noted that the amount of Miz1 
present in detergent lysates was decreased upon cotransfection 
of p14Arf; this effect was particularly apparent when high lev-
els of Arf were expressed (Fig. 2 d). Arf had no effect on the   
expression of the MIZ1 mRNA levels; therefore, the result is   
not caused by Arf-dependent inhibition of the CMV promoter   
(unpublished data). Furthermore, treatment of cells with MG132, 
an inhibitor of the proteasome, did not enhance recovery of 
Miz1 (unpublished data). In contrast, extracting cells with 
4% SDS at 95°C led to recovery of Miz1, demonstrating that 
p14Arf renders Miz1 insoluble (Fig. 2 d). Notably, this change 
in solubility correlated with a striking intranuclear relocaliza-
tion of Miz1 from a homogeneous distribution throughout the 
nucleoplasm to a localization in distinct subnuclear foci in re-
sponse to Arf (Fig. 2 e and Fig. S1 b).
Because resistance to detergent extraction often correlates 
with formation of heterochromatin, we used chromatin immuno-
precipitation with antibodies directed against several histone 
modifications to analyze how repression of Miz1 by Arf affects 
the chromatin structure of Miz1 target genes. No change was 
observed using antibodies directed against trimethylated K27 of 
histone H3 (unpublished data). In contrast, expression of Arf led 
to a strong increase in the amount of histone H3 trimethylated   
at lysine 9 (H3K9
trime), a defining feature of heterochromatin,   
at the Miz1-binding site of the P15INK4B and P21CIP1 genes 
(Fig. 2 f and not depicted). Collectively, the data argue that   
Arf induces the local formation of heterochromatin at Miz1-
  binding sites.
p14Arf is encoded by two exons: amino acids 1–64 are en-
coded by exon 1 of the CDKN2A locus and are sufficient to in-
hibit Mdm2 and cause p53-dependent cell cycle arrest (Kamijo 
et al., 1998; Clark et al., 2002). Amino acids 65–132 are encoded 
by exon 2, which is shared with p16Ink4a; these amino acids 
contribute to induction of apoptosis by Arf (Itahana and Zhang, 
2008). To determine which of the two domains binds to Miz1, 
we coexpressed Miz1 with a full-length Arf-GFP fusion protein 
and two deletion mutants lacking the first 50 and 64 amino acids, 
respectively (Fig. 3 a). All three proteins efficiently coimmuno-
precipitated Miz1, demonstrating that amino acids 65–132 of the 
human Arf protein are sufficient for the interaction.
Reporter assays revealed that binding of Arf to Miz1 is not 
sufficient to inhibit Miz1 function because amino acids 65–132 
of Arf were inefficient in inhibiting Miz1-dependent transacti-
vation and sequestering of Miz1 (Fig. 3 b and Fig. S2). The 
amino terminus of p14Arf is required for interaction with Myc 
(Fig. 3 a; Datta et al., 2004). Because Myc can repress transacti-
vation by Miz1, we speculated that recruitment of Myc might 
be required for p14Arf to repress Miz1 function. Consistent JCB • VOLUME 188 • NUMBER 6 • 2010   910
(Fig. 5 a; Quelle et al., 1995). Expression of either wild-type 
Miz1 or Miz1 S428A, a point mutant that cannot be phos-
phorylated by Akt, had only moderate effects on cell cycle 
progression by itself, potentially because U2OS cells express 
significant levels of endogenous Myc when grown exponen-
tially in culture (Fig. 5 b). In clear contrast to cells expressing   
p53-proficient cell, we expressed p14Arf and Miz1 either alone 
or together via retroviral infection in U2OS cells in which the 
endogenous ARF gene is silenced but that have wild-type p53 
(Park et al., 2002). Expression of Arf inhibited cell prolifera-
tion and led to an increase in the percentage of cells in the G1 
phase of the cell cycle, which is consistent with published data 
Figure 3.  Inhibition of Miz1 by p14Arf requires assembly of the Myc–Miz1 complex. (a) Miz1 and Myc interact with different domains of p14Arf. U2OS 
cells were transfected with expression vectors encoding Miz1 and the indicated p14Arf-GFP fusion proteins as indicated. Lysates were precipitated with   
-GFP antibodies and immunoblots of the precipitates probed with the indicated antibodies. The top diagram illustrates the amino acids encoded by exons 
1 and 2 and gives a summary of the interaction assays. The blots below document the results of the coimmunoprecipitation experiments. (b) Binding of p14Arf   
to Miz1 is not sufficient to inhibit transactivation. (top) The result of transient reporter assays using the indicated expression plasmids and a P15INK4B  
reporter plasmid is shown. (bottom) Immunoblots documenting expression of the indicated proteins are shown. (c) Expression of p14Arf recruits Myc to 
Miz1 foci. Confocal microscopy pictures of HeLa cells transfected with the indicated expression vectors are shown. Cells were stained with the antibod-
ies shown. Pictures of individual cells were used to calculate correlation coefficients indicating colocalization. The numbers shown are mean values for 10 cells   
each. (d) Mutants of Miz1 that are impaired in binding to Myc bind to Arf. (left) The mutants used are shown and their strength of interaction with Myc 
is indicated (data adapted from Peukert et al., 1997). (right) Immunoblots documenting that all three mutant alleles bind to Arf with similar efficiency are 
shown. The experiment was performed as in Fig. 1 a. wt, wild type. (e) Miz1 mutants that are deficient in Myc binding are poorly sequestered by Arf. HeLa 
cells were transfected with the indicated expression vectors and extracted with either a buffer containing low salt and nonionic detergent (low salt lysis; 
see Materials and methods) or with buffer containing 4% SDS at 95°C (SDS lysis). Immunoblots of the soluble material are shown. (f) Mutants of Miz1 that 
are impaired in binding to Myc are resistant to inhibition by Arf. The degree by which increasing amounts of Arf inhibit transactivation by each mutant 
(calculated from P15INK4B reporter assays) is indicated. (g) Miz1∆75 does not form foci in response to expression of Arf. The experiment was performed 
as described in Fig. 2 e for wild-type Miz1. IP, immunoprecipitate; ctr, control. Error bars represent standard deviation of biological triplicates.911 Arf inhibits Miz1 • Herkert et al.
Figure 4.  Arf antagonizes NPM in the assembly of a repressive Myc–Miz1 complex and promotes sumoylation of Miz1. (a) Expression of p14Arf disrupts 
the NPM–Miz1 complex. HeLa cells were transfected with expression plasmids encoding Miz1, p14Arf, and HA-tagged NPM as shown. 48 h after trans-
fection, cells were lysed and lysates were immunoprecipitated with either control (ctr) or -HA antibodies. Immunoblots of the precipitates were probed 
with the indicated antibodies. (left) Input blots are shown. IP, immunoprecipitate. (b) Expression of NPM inhibits sequestration of Miz1 by Arf. HeLa cells 
were transfected with expression vectors for Miz1, Arf, and NPM as shown. 48 h after transfection, cells were lysed in low salt buffer. Immunoblots of the 
soluble fraction were probed with the indicated antibodies. (c) Expression of NPM antagonizes Arf-induced foci formation. HeLa cells were transfected 
with expression vectors for NPM and either Miz1, Arf, or both and processed for immunofluorescence. Note that the relocalization of NPM and Arf to 
the nucleus is almost certainly caused by residual binary Miz1–NPM and Miz1–Arf complexes in the transfected cells. (d) p14Arf induces colocalization 
of Miz1 into foci with Sumo2. Immunofluorescence pictures of HeLa cells transfected with expression plasmids encoding Miz1, p14Arf, and Sumo2 as 
shown; transfected cells were stained with the indicated antibodies. (e) Recruitment of Sumo2 to Myc–Miz1 foci requires Ubc9. Cells were transfected with 
either control siRNA or siRNA targeting Ubc9 and subsequently transfected and processed for immunofluorescence as described in b. (bottom) The Ubc9 
knockdown is documented. (f) Arf induces sumoylation of Miz1. HeLa cells were transfected with the indicated expression plasmids; 48 h later, cells were 
lysed in denaturing buffer, and sumoylated proteins were recovered on Ni-NTA agarose. (g) Depletion of Myc reduces Arf-induced sumoylation of Miz1. 
Sumoylation assays were performed as described in e except that HeLa cells were transfected with either control siRNA or siRNA targeting Myc. Rr indicates 
the Pearson’s coefficient for the correlation of the localization of both proteins.JCB • VOLUME 188 • NUMBER 6 • 2010   912
revealed that this change in cellular behavior occurred with-
out any detectable changes in the expression of either Miz1 
or Arf (Fig. 5 b). We noted that levels of endogenous Myc 
were elevated in cells expressing Miz1, reflecting the ability 
of Miz1 to stabilize Myc (Salghetti et al., 1999).
either  Miz1  or  Arf  alone,  cells  expressing  both  proteins   
underwent rampant apoptosis as demonstrated by the accu-
mulation of cells with a sub-G1 DNA content. Virtually iden-
tical results were obtained when activation of caspase 3 was 
used as a marker for apoptosis (Fig. S3 a). Immunoblotting 
Figure 5.  Binding of Myc to Miz1 switches the cellular response to Arf from cell cycle arrest to apoptosis. (a) Coexpression of Miz1 and Arf induces 
apoptosis in p53-proficient cells. U2OS cells were sequentially infected with either control retroviruses or viruses expressing the indicated proteins. Pools 
of resistant cells were selected and harvested for FACS analysis immediately after selection. (b) Immunoblots documenting expression of the indicated 
proteins in the U2OS cells used for the analysis shown in a. Note the enhanced levels of endogenous Myc expression in cells expressing ectopic Miz1 or 
Miz1S428A. (c) Arf does not recruit MycV394D into nuclear foci. Confocal microscopy pictures documenting the distribution of MycV394D and of Miz1 in 
HeLa cells expressing both proteins and p14Arf are shown. (d) Binding of Myc to Miz1 stimulates induction of apoptosis by Myc and Arf. U2OS cells were 
infected and harvested as described in a. The plot shows the difference in the percentage of apoptotic cells and of cells in the indicated phase of the cell 
cycle observed in cells expressing the indicated proteins relative to control-infected cells. (e) Immunoblots documenting expression of the indicated proteins 
in the cells used for the analysis shown in d. wt, wild type. Rr indicates the Pearson’s coefficient for the correlation of the localization of both proteins. Error 
bars represent the standard deviation of biological triplicates.913 Arf inhibits Miz1 • Herkert et al.
expression of each member of this group was analyzed indi-
vidually (Fig. S4 a). We analyzed 10 of these genes by chroma-
tin immunoprecipitation and found that Miz1 bound to the start 
site of all of them (Fig. 6 d). Coexpression of Arf and Miz1 pro-
moted  the  accumulation  of  trimethylated  H3K9  around  the 
Miz1-binding sites on 8/10 genes (Fig. 6 e). Furthermore, real-
time quantitative PCR (RQ-PCR) experiments from indepen-
dent experiments showed that expression of these genes was 
repressed upon coexpression of Miz1 and Arf but much less 
upon coexpression of Miz1∆75 and Arf, paralleling the effect of 
adhesion, and arguing that repression by Miz1 and Arf requires 
recruitment of Myc (Fig. S4 b and Table S1). We used chroma-
tin immunoprecipitations to analyze a subset of these genes and 
confirmed  that  endogenous  Myc  was  bound  to  the  Miz1- 
binding site in vivo (Fig. S4 c).
To determine how this change in gene expression trans-
lates into alterations in cellular behavior, we infected U2OS 
cells as before and trypsinized the cells 2 d after infection; at 
this time point, only a minority of cells had already undergone 
apoptosis. Upon replating, cells expressing either Miz1 or Arf 
by itself rapidly reattached; in contrast, cells coexpressing Miz1 
and Arf failed to attach to the dish (Fig. 7 a). Loss of adhesion 
was not observed in cells coexpressing Arf and Miz1∆75, argu-
ing that it was depending on binding of Myc to Miz1.
We repeated the experiment by infecting adherent cells 
that express either Miz1 or Miz1∆75 with a retrovirus express-
ing Arf and selecting pools of infected cells without trypsiniza-
tion. In this experimental setting, expression of Arf led to rapid 
loss of adhesion of cells expressing Miz1 but not of control cells 
or cells expressing Miz1∆75 (Fig. 7 b). Similarly, cells express-
ing Myc + Arf but not MycV394D + Arf rapidly detached from 
the plate (Fig. S5 a). Furthermore, identical results were ob-
tained when adherent cells were infected with a high titer lenti-
virus expressing Arf and subsequently cultured without drug 
selection (unpublished data). Under these experimental condi-
tions, cells that detached from the plate underwent apoptosis, 
whereas the remaining adherent cells did not, showing that loss 
of adhesion is tightly linked to induction of apoptosis (Fig. S5 b). 
Importantly, retroviral expression of Bcl2 suppressed the apop-
tosis induced by coexpression of Miz1 + Arf or Myc + Arf but   
had no discernible effect on the loss of adhesion (Fig. 7, b and c; 
and Fig. S5 a). Together, the data strongly argue that the re-
pression of cell adhesion genes and the resultant altered adhe-
sion properties are the cause, not the consequence, of induction 
of apoptosis.
Discussion
In this study, we show that the Arf tumor suppressor protein   
facilitates two distinct steps in the assembly of a heterochro-
matic complex that contains Myc, Miz1, Sumo2, and trimethyl-
ated H3K9 (Fig. 8). One of these steps occurs independently of 
Ubc9: this step requires binding of Myc to Miz1 and leads to an 
altered intranuclear localization and solubility of Miz1 that is 
characteristic of Myc–Miz1 complexes. Previous work has 
shown that NPM is a coactivator of Miz1 and that Myc inhibits 
binding of NPM to Miz1 (Wanzel et al., 2008). Also, direct 
Levels of endogenous Myc were even further elevated in 
cells expressing Miz1 and Arf, suggesting that the switch from 
cell cycle arrest to apoptosis requires formation of the Myc–
Miz1 complex. Consistent with this idea, coexpression of Arf 
with Miz1∆75 induced significantly less apoptosis relative to   
coexpression of Arf with wild-type Miz1 (Fig. S3 c). As a further 
test of this idea, we coexpressed Arf with either wild-type Myc 
or MycV394D, a point mutant of Myc that does not associate 
with Miz1 (Herold et al., 2002). Confocal immunofluorescence 
confirmed that Arf does not recruit MycV394D into Miz1- 
containing nuclear foci (Fig. 5 c). Expression of wild-type Myc 
abrogated Arf-induced G1 arrest and induced apoptosis, similar 
to what was observed in the presence of Miz1 and Arf (Fig. 5,   
d and e; and Fig. S3 b). In contrast, MycV394D was significantly 
compromised in its ability to overcome Arf-induced G1 arrest 
and induce apoptosis when coexpressed with Arf, demonstrating 
that induction of apoptosis by Arf requires formation of the 
Myc–Miz1 complex (Fig. 5, d and e; and Fig. S3 b).
To understand how Arf affects Miz1-dependent gene   
expression and induces apoptosis, we performed genome-wide   
microarray analysis on RNA extracted from U2OS cells infected 
with retroviruses expressing either Miz1, Myc, or Arf either   
by themselves or in combination to identify the target genes 
jointly regulated by Myc and Miz1 in the presence of Arf. This 
analysis showed that expression of Arf enhanced the ability   
of Myc and Miz1 to repress transcription. Specifically, Miz1   
repressed 322 genes more than twofold in the presence of Arf 
but only 100 genes in its absence; similarly, expression of Arf 
enhanced the number of Myc-repressed genes from 50 to 126 
(Fig. 6 a). Importantly, 64 of the 126 genes were also repressed 
when  Miz1  and Arf  were  coexpressed,  identifying  a  highly   
significant overlap in target genes (P = 2.5 × 10
92) and defining 
a core program of genes that are jointly repressed by Myc and 
Miz1 in the presence of Arf (Fig. 6 b). Arf also induced qualita-
tive differences in gene repression by Myc and Miz1; notably, 
only 30 of the 126 genes that were repressed by Myc in the pres-
ence of Arf and 12 of the 322 genes repressed by Miz1 in the 
presence of Arf were also repressed in its absence.
We  considered  several  hypotheses  of  how  repression   
of the target genes of the Myc–Miz1 complex might shift the 
cellular response to expression of Arf toward apoptosis. First, 
none of the 64 genes that were repressed by either Myc or Miz1 
in the presence of Arf were a target gene of p53 as judged by 
comparison with a database of genomic binding sites for p53 (Wei 
et al., 2006). Therefore, we ruled out a model in which Arf in-
duces apoptosis by shifting the p53-dependent transcriptional   
response toward proapoptotic genes via its effects on the Myc–
Miz1 complex. Second, none of the genes encoded a mitochon-
drial protein, suggesting that direct alterations of the apoptotic 
machinery are also not responsible for the shift in the cellular 
response. Instead, Gene Ontology (GO) term analysis (Fig. 6 c) 
showed that coexpression of either Myc or Miz1 with Arf re-
pressed a set of genes that is highly enriched for genes encoding 
proteins involved in cell adhesion and as coreceptors in signal 
transduction. This group of genes was not repressed by either 
Miz1 or Arf alone and only weakly by expression of Myc alone 
(Fig. 6 c). Arf-enhanced repression was also apparent when the JCB • VOLUME 188 • NUMBER 6 • 2010   914
Figure 6.  Arf-mediated assembly of the Myc–Miz1 complex represses genes involved in cell adhesion. (a) Expression of Arf regulates gene repression   
by Myc and Miz1. A summary of several microarray experiments is shown. U2OS cells were infected with either control retroviruses or with retroviruses   
expressing the indicated proteins. After selection of resistant cell pools, RNA was extracted and used for microarray experiments. Two Venn diagrams 
describing the overlap in genes down-regulated more than twofold in each experimental condition are shown. (b) Myc and Miz1 repress an overlapping 
set of genes in the presence of Arf. A Venn diagram illustrating the overlap in genes repressed by twofold or more in cells expressing Myc plus Arf or Miz1 
plus Arf relative to control cells is shown. The p-value was calculated with a hypergeometric test against a null hypothesis of random selection. (c) Myc and 
Miz1 jointly inhibit cell adhesion genes in the presence of Arf. Results of a GO term analysis using DAVID are shown. The five most significant GO terms 
describing biological processes affected by genes down-regulated by Miz1 + Arf and Myc + Arf are shown. For each term, the p-value is given for genes 
down-regulated in cells infected with the indicated expression vectors. Whenever a GO term was not significant for a gene set, the value was arbitrarily 
set to 1. (d) Miz1 binds to the start sites of multiple cell adhesion genes and promotes H3K9 trimethylation. The results of chromatin immunoprecipitation 
(ChIP) experiments from U20S cells expressing the indicated proteins are shown. (e) Expression of Miz1 and Arf promotes H3K9 trimethylation at promo-
tors of multiple cell adhesion genes. The result of chromatin immunoprecipitation experiments performed as described in d is shown. ctr, control. Asterisks 
indicate statistical significance: *, P < 0.05; **, P < 0.01. Error bars represent standard deviation of triplicate PCR reactions.915 Arf inhibits Miz1 • Herkert et al.
Arf-dependent sumoylation of Miz1, suggesting that formation of 
the Myc–Miz1 complex facilitates sumoylation. Because sumoyla-
tion of transcription factors can mediate the recruitment of corepres-
sors, it is tempting to speculate that sumoylation of Miz1 enhances 
repression by the Myc–Miz1 complex (Stielow et al., 2008; Ouyang 
et al., 2009). It remains to be determined whether Arf-induced   
sumoylation of Miz1 is mediated via inhibition of the Senp3 Sumo-
specific protease (Haindl et al., 2008; Kuo et al., 2008).
binding of Arf to Myc has been demonstrated previously (Qi et al., 
2004). Therefore, the simplest model that explains our data is that 
Arf facilitates the recruitment of Myc to Miz1, thereby displacing 
NPM. This model can explain our observation that elevated levels 
of NPM disrupt foci formation because free NPM would compete 
with Miz1–NPM complexes for binding to Arf and Myc. Next,   
Arf promotes sumoylation of Miz1, similar to other proteins to 
which it binds (Tago et al., 2005). Depletion of Myc attenuates   
Figure  7.  Expression  of  Miz1  and  Arf  re-
sults in reduced cell adhesion and subsequent 
apoptosis. (a) U2OS cells expressing Miz1 
and Arf show strongly reduced cell adhesion. 
Morphology  of  U2OS  cells  expressing  the 
indicated proteins. Pools of resistant cells ex-
pressing the indicated protein were selected, 
trypsinized,  and  replated.  (top)  Photographs 
taken 2 h after replating are shown. (bottom) A 
quantitation of the experiment is shown. Simi-
lar results were obtained after 4 h and also in 
cells expressing Myc plus Arf (not depicted). 
(b)  Loss  of  cell  adhesion  upon  coexpression 
of Miz1 and Arf is not affected by expression   
of Bcl2. U2OS cells were infected with either 
control (ctr) retroviruses or retroviruses express-
ing the indicated proteins. Pools of resistant 
cells were selected without trypsinization. Pho-
tographs were taken 4 d after infection. (c) Ex-
pression of Bcl2 reduces apoptosis induced by 
coexpression of Miz1 and Arf. U2OS cells de-
scribed in b were harvested for FACS analysis. 
The graph shows the percentage of apoptotic 
cells. wt, wild type. Error bars represent the 
standard deviation of biological triplicates.JCB • VOLUME 188 • NUMBER 6 • 2010   916
Several of the genes encoding these molecules are targets of 
Myc–Miz1 complexes and, therefore, would be repressed in 
cells expressing Arf (Frye et al., 2003; Gebhardt et al., 2006). 
This  second  mechanism  could  explain  the  p53-independent   
tumor-suppressive role of Arf that has been demonstrated dur-
ing skin carcinogenesis (Kelly-Spratt et al., 2004). Finally, we 
note that the enhanced levels of NPM that are found in many   
tumor cells would antagonize repression of cell adhesion genes 
and subsequent apoptosis mediated by Myc–Miz1 complexes, 
providing a potential mechanistic explanation for the potent abil-
ity of NPM to enhance transformation by Myc (Li et al., 2008).
Materials and methods
Cell culture
All cell lines were grown in DME. Media were supplemented with 10% heat-
inactivated fetal calf serum (Sigma-Aldrich), 2 mM L-glutamine, 100 U ml
1 
penicillin, and 100 µg ml
1 streptomycin. mdm2/p53/arf- and NPM/p53-
deficient MEFs were provided by C. Sherr and M. Roussel (St. Jude Children’s 
Research Hospital, Memphis, TN) and P.-G. Pelicci (Istituto Europeo di   
Oncologia, Milan, Italy), respectively. Recombinant retroviruses were   
generated and used as described previously (Pear et al., 1993).
U2OS cells were stably transfected with an ecotropic receptor 
expression plasmid before infection. Infected cells were selected and 
analyzed within one to two passages after selection. Cells used for 
double infection with two different viruses were split 1 d after infection 
and superinfected 24 h later. Selection was performed 2 d after the 
second infection.
For lentiviral infections, the pLV-tTRKRAB-red vector with p14Arf   
replacing the tTRKRAB element, the packaging plasmid psPAX.2, and 
the envelope plasmid pMD2.G were used. 293T producer cells were triple 
transfected with these vectors, supernatant containing lentiviral particles 
was harvested 36 h after transfection, and U2OS cells were infected in the 
presence of 4 µg/ml protamine sulfate (Sigma-Aldrich).
Transient transfection and siRNA transfection
Transient transfection of plasmid DNA was performed using a standard 
CaPO4 protocol. The expression and reporter plasmids were described 
previously (Wanzel et al., 2008). siRNAs targeting Ubc9 and c-Myc were 
purchased from Thermo Fisher Scientific, and transfection was performed 
using reagent (Lipofectamine RNAiMAX; Invitrogen) according to the   
manufacturer’s instructions. Cells were harvested 48 h after transfection 
and lysed directly in buffer containing 190 mM Tris, pH 6.8, 30% glycerin, 
2 M -mercaptoethanol, and 4% SDS at 95°C (SDS lysis). Low salt lysis 
was performed with a buffer containing 25 mM glycylglycine, 15 mM 
MgSO4, 4 mM EGTA, and 1% (vol/vol) Triton X-100.
Miz1 arrests cell proliferation in a p21-dependent manner 
in the G1 phase of the cell cycle and in a p21-independent, Atr-
dependent manner in the S and G2 phases of the cycle (Herold 
et al., 2008). Expression of Arf has no effect on Miz1-mediated 
G2 arrest but abrogates the G1 arrest, which is consistent 
with the ability of Arf to inhibit Miz1-dependent transcrip-
tional activation. Furthermore, the interaction of Arf with Miz1 
leads to repression of a large group of genes that encode pro-
teins involved in cell adhesion and cell signaling and closely 
correlates with induction of apoptosis by Miz1 and Arf. Two 
previous studies have linked Myc’s apoptotic function to Miz1-
dependent repression of Bcl-2 and p21Cip1 (Seoane et al., 
2002; Patel and McMahon, 2007), respectively. Furthermore, a 
recent study suggests that Miz1 might inhibit expression of Bax 
and Puma and that Arf might relieve this inhibition (Miao et al., 
2010). However, we did not observe regulation of any of these 
genes in our experimental settings, arguing that additional tar-
gets of this pathway must exist. Indeed, expression of either 
Miz1 or Myc together with Arf led to repression of a group of 
genes encoding proteins involved in both cell–cell and cell–matrix 
adhesion. Previous studies have shown that Myc can inhibit cell 
adhesion in hematopoietic and epithelial cells and have impli-
cated  Miz1-mediated  repression  in  this  process  (Frye  et  al., 
2003; Wilson et al., 2004; Gebhardt et al., 2006).
The findings suggest a model in which induction of Arf 
and subsequent repression via the Myc–Miz1 complex reduces 
or disrupts the interaction of a cell that has sustained an onco-
genic mutation with its environment. This mechanism would be 
tumor suppressive because many epithelial cells depend on con-
tinuing contact with a substratum to escape anoikis (Reginato   
et al., 2003). Indeed, several of the genes repressed by Myc–
Miz1 in the presence of Arf encode coreceptors of growth factor 
receptors, arguing that their repression may lead to loss of criti-
cal survival signals (Orian-Rousseau et al., 2002). Second, most 
epithelial cells undergo rapid turnover and do not reside long 
enough in a tissue to acquire the multiple mutations required   
for tumorigenesis. The exceptions are stem cells, which depend 
on specific cell adhesion molecules for retention in the niche.   
Figure  8.  Model summarizing our findings. 
We propose that NPM and Arf have antago-
nistic roles in Miz1-dependent transactivation 
and Myc–Miz1-mediated repression of genes. 
Arf  also  stimulates  the  sumoylation  of  Miz1 
potentially by antagonizing the Sumo-specific 
protease Senp3.917 Arf inhibits Miz1 • Herkert et al.
(reverse) 5-TCGTTGCCAGTACAGTGGAG-3; CDH4 (forward), 5-CAGA-
CCCCGTAACCAACG-3 and (reverse) 5-TGAAAGCTCTGTTGAGCT-
CGT-3; ITGA6 (forward), 5-AGCCTCTTCGGCTTCTCG-3 and (reverse) 
5-CTCCCGTTCTGTTGGCTCT-3; COL8A1 (forward), 5-CATGGACTTCC-
TGGCATTG-3 and (reverse) 5-TCGATCACCCTTTGGTCCT-3; COL13A1 
(forward),  5-GGGAGAAGCAGGTGTCGAT-3  and  (reverse)  5-GGC-
CATCTGGTCCCTGTT-3; and PTX3 (forward), 5-TGTATGTGAATTTGGA-
CAACGAA-3 and (reverse) 5-CATTCCGAGTGCTCCTGAC-3.
Online supplemental material
Fig. S1 shows cellular Interactions of Miz1 and Arf. Fig. S2 shows that 
p14Arf(65–132) fails to sequester Miz1. Fig. S3 shows that Arf-induced 
assembly of the Myc–Miz1 complex promotes apoptosis. Fig. S4 shows 
expression  data  for  individual  genes  in  the  adhesion  cluster.  Fig.  S5 
shows loss of adhesion in cells expressing Myc and Arf. Table S1 shows 
p-values for the differences in expression of the adhesion genes shown 
in Fig. S4. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.200908103/DC1.
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Antibodies, chromatin immunoprecipitation, and immunofluorescence
A rabbit polyclonal antibody was used to precipitate Miz1 (H-190; Santa 
Cruz Biotechnology, Inc.), mouse monoclonal antibody 10E2 was used for 
immunoblotting, and both antibodies were used for immunofluorescence. 
The following antibodies were used for immunofluorescence and immuno-
blotting: p19Arf (Abcam), p14Arf (Novus Biologicals), mouse monoclonal 
anti-Myc antibody (9E10), anti-NPM (FC82291; Abcam), anti-HA (16B12; 
Covance), anti-Cdk2 (Santa Cruz Biotechnology, Inc.), anti-Flag (F3165; 
Sigma-Aldrich), anti–-actin (clone AC-15; Sigma-Aldrich), anti-Ubc9 (Abcam), 
anti-GFP (Sigma-Aldrich), anti-H3K9
trime (Abcam), and anti-p53 (DO-1; Santa 
Cruz Biotechnology, Inc.).
Fluorescence  images  were  recorded  on  a  confocal  microscope 
(SP5; Leica) with a 63× NA 1.4 oil immersion objective. The fluorescence 
emission resulted from excitation with 405- (for Hoechst), 488- (for Alexa 
Fluor 488, fluorescein, and GFP), and 633 (for Alexa Fluor 647)-nm laser 
lines with a confocal microscope (SP5 LSM; Leica) using internal spectral 
parameter settings. The fluorescence was detected using a 430–470-nm 
spectral bandwidth setting for Hoechst, a 505–570-nm spectral bandwidth 
setting for Alexa Fluor 488, and a 650–720-nm spectral bandwidth setting 
for Alexa Fluor 647. To avoid bleeding between channels, each excitation 
and emission was recorded individually and sequentially in each focal 
plane. Each image was line and frame averaged twice. For consistency, 
the internal settings were kept constant for all samples. The correlation of 
fluorescence intensities was evaluated with LAS AF software (Leica) to   
determine the Pearson’s coefficient.
FACS analysis
For analysis of the cell cycle profile/distribution, cells were fixed in ethanol 
and stained with propidium iodide. To determine the level of apoptosis, 
cells  were  labeled  using  the  CaspGlow  Fluorescein  Active  Caspase-3 
Staining kit (BioVision) according to the manufacturer’s instructions.
In vivo sumoylation assays
HeLa cells were transfected with combinations of CMV-driven expression 
vectors for Miz1, Arf (provided by G. Peters, London Research Institute, 
London, England, UK), and a His-Sumo2 expression plasmid (provided by 
G. Suske, University of Marburg, Marburg, Germany). 48 h after transfec-
tion, cells were harvested, lysed in buffer A (6 M guanidinium-HCl, 0.1 M 
Na2HPO4/NaH2PO4, pH 8.0, 250 mM sodium chloride, 10 mM imid-
azole, and 0.1 mM N-ethyl maleimide), sonicated, and cellular debris was 
removed by centrifugation. The lysate was incubated with Ni-NTA beads 
(QIAGEN) for 4 h at 4°C to purify His-tagged proteins. The beads were 
washed two times with buffer A, two times with a 1:4 mixture of buffer A 
and buffer B (25 mM Tris–HCl, pH 6.8, and 20 mM imidazole), and two 
times with buffer B. Bound proteins were eluted by boiling in SDS sample 
buffer containing 200 mM imidazole, and eluted proteins were ana-
lyzed by Western blotting.
Microarray procedures
We used a whole human genome microarray kit (G4112F; Agilent Technol-
ogies), and procedures were performed according to the manufacturer’s   
instructions. Samples were prepared from 100 ng total RNA. The Cy3- and 
Cy5-labeled probes were hybridized to microarrays for 16 h at 65°C and 
according to the manufacturer’s instructions. Data analysis was performed 
using the limma package (Wettenhall and Smyth, 2004) and R (http://
www.R-project.org). Genes were selected as regulated if they had minimum 
mean log2 expression of 5 and a minimum fold change of 2. Multiple 
probe sets for one gene were averaged before selection. The experiments 
were performed in duplicates, and independent arrays were performed 
from each sample. Genes were filtered by reproducibility, and a set of 
genes was validated by RQ-PCR (Absolute QPCR SYBR green mix; Thermo 
Fisher Scientific). (max (1, (array_1 + array_2)/2) > |array_1  array_2|). 
GO term group analysis was performed using DAVID (Database for Annota-
tion, Visualization, and Integrated Discovery; Dennis et al., 2003).
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